Aline Rigon Zimmer is currently an Associate Professor at the Federal University of Rio Grande do Sul (UFRGS), permanent member of the Pharmaceutical Sciences Graduate Program (PPGCF), and affiliate member at the Montreal Neurological Institute and Hospital of McGill University. The primary research interest is developing new therapeutic agents targeting chronic multifactorial disorders with complex pathophysiological processes such as metabolic, neurodegenerative, and inflammatory diseases. Experience in medicinal chemistry and the development of platforms for drug discovery using in silico, in vitro, and in vivo models. The research lines focus on evaluating the effects of new drug candidates, from synthetic or natural sources, on metabolic disorders and the impact on functional connectivity and neurovascular coupling in dementia models.